AVE 0.00% 0.3¢ avecho biotechnology limited

the dream machine

  1. 5,322 Posts.
    Harry Rosen our POH President and CEO) gets my vote as the International Man of Action 2010.

    He is spending 6 months of the year in the USA wooing potential investors and courting Pharma for that much awaited deal(s)- abley assisted by his Wingman Fred Banti.

    The rest of his time is spent at POH headquarters overseeing his embrionic Biotech Empire.

    My point is many have judged the company harshly in 2009 on its lack of visibility...while being oblivious to what has being brewing behind the scenes...and that has been where the company focus was..until NOW.

    We are just now beginning to see fruits of these labours. If the year to date is any indication- 2010 wil be THE Year for POH.

    I can understand the current SP machinations are frustrating for newcomers to POH- but as Harry often says- let me get the science right- the deals will follow-and the SP will take care of itsself.

    With an Oxcodone Blockbuster deal near(Global Sales USD $3.5 Billion); a maturing pipeline featuring Dyclofenac (Global Sales USD$1 Bill); Tretinoic Acid ; Lidocaine; and biggest of all- Transdermal Insulin as the Jewel in our crown, our prospects for success are a safe bet to say the least.

    We then have support acts to come from CSL and Metabollic Collaborations plus our Cosmacueticals Division as a nice cashcow. This already is generating some $2m in earnings from our ISP sales in the USA and soon will be supplemented with a further sales boost fromo our new Aussie(Elixia) and USA (Le Metier) OTC cremes and potions.

    See the current POH research Pipeline here:
    http://www.phosphagenics.com/site/DefaultSite/filesystem/documents/R&D%20Pipeline%20August%202009.pdf

    The question is not when will we have our first deal - but how many will we have.

    And as we can see from the big action over at OBJ today- there is nothing like a deal with a significant Pharma player to create a multi bagger ( congrats to all our new friends at OBJ thread- proves that there is money in the Biotech sector and that patience is required to make it).

    Better check on the Grange...it wont collect dust for much longer

    KC
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $7.923M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
54 86239613 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 63389028 18
View Market Depth
Last trade - 12.26pm 31/07/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.